2021 annual financial data

Aquestive Therapeutics 2021 Net margin

Direct answer

Net margin was -138.77%.

Operating income was -34,679,000 USD and net income was -70,539,000 USD.
Operating cash flow was -32,979,000 USD.

Get free Aquestive Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
50,832,000 USD
Operating income
-34,679,000 USD
Net income
-70,539,000 USD
Operating cash flow
-32,979,000 USD